Advances in Recombinant Lipases: Production, Engineering, Immobilization and Application in the Pharmaceutical Industry

Достижения в области рекомбинантных липаз: получение, инженерия, иммобилизация и применение в фармацевтической промышленности
Uffe Hasbro Mortensen, Marcelo Gomes Davanço, Kristiina Hildén, Gustavo Borin, Patrícia de Oliveira Carvalho, Ricardo Rodrigues de Melo, Fabiano Jares Contesini, Katherina García Vanegas, João Pedro Gonçalves Cirino, Daniel Rossi de Campos
2020-09-09

directed evolutionenzyme immobilizationpharmaceutical industryprotein engineeringrecombinant lipases
Lipases are one of the most used enzymes in the pharmaceutical industry due to their efficiency in organic syntheses, mainly in the production of enantiopure drugs. From an industrial viewpoint, the selection of an efficient expression system and host for recombinant lipase production is highly important. The most used hosts are Escherichia coli and Komagataella phaffii (previously known as Pichia pastoris) and less often reported Bacillus and Aspergillus strains. The use of efficient expression systems to overproduce homologous or heterologous lipases often require the use of strong promoters and the co-expression of chaperones. Protein engineering techniques, including rational design and directed evolution, are the most reported strategies for improving lipase characteristics. Additionally, lipases can be immobilized in different supports that enable improved properties and enzyme reuse. Here, we review approaches for strain and protein engineering, immobilization and the application of lipases in the pharmaceutical industry.
1
Efficient recombinant lipase overproduction often requires strong promoters and co-expression of molecular chaperones.
2
Escherichia coli and Komagataella phaffii are the most commonly used hosts for recombinant lipase production, while Bacillus and Aspergillus are less frequently reported.
3
Immobilizing lipases on suitable supports can enhance their properties and enable enzyme reuse in pharmaceutical applications.
4
Lipases are widely used in pharmaceutical organic synthesis, particularly for producing enantiopure drugs.
5
Rational design and directed evolution are the principal protein-engineering strategies reported for improving lipase characteristics.

Recombinant lipases used in the pharmaceutical industry

Production, protein engineering, immobilization, and pharmaceutical applications of lipases, including improvement of their properties and reuse

Publication Details
Publication Date
2020-09-09
Journal
Publisher
ISSN
Cited by
108
Access Type
Author Information
Authors
Uffe Hasbro Mortensen
Marcelo Gomes Davanço
Kristiina Hildén
Gustavo Borin
Patrícia de Oliveira Carvalho
Ricardo Rodrigues de Melo
Fabiano Jares Contesini
Katherina García Vanegas
João Pedro Gonçalves Cirino
Daniel Rossi de Campos
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%